Medication info

Aclast Tablet 375 mg (Amoxicillin-Potassium Clavulanate (2:1))

Prescription medicationTabletOralExpired
Ingredient · strength
Amoxicillin Hydrate›250mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Arie Pharmaceutical Co., Ltd.
Appearance
It is an oval film-coated tablet that is white or almost white.
Packaging
100 tablets/box[(10 tablets/PTP*10)], 96 tablets/box[(8 tablets/PTP*12)], 80 tablets/box[(8 tablets/PTP*10)]
Approval status
Expired

MFDS item code 202008262 · Approved 2020.11.26

This product's status changed to Expired on 2025.11.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of respiratory, genitourinary, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The appropriate dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. ○ Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).
Child dose
○ Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. - Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Arie Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory, genitourinary, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This drug is effective against various bacterial infections. It is used to treat respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It also has efficacy against urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is effective for sexually transmitted diseases such as pelvic infections and gonorrhea, and helps treat boils, abscesses, soft tissue infections, and osteomyelitis. It is also used to treat dental infections, thus used to improve various bacterial infections.

How to take

Adult dose

The appropriate dose of this drug should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the beginning of a meal. ○ Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is necessary in patients with creatinine clearance (CrCl) of 30 mL/min or higher. 10 ~ 30 mL/min Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis Administer amoxicillin/potassium clavulanate 250mg/125mg or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanate decrease).

Child dose

○ Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. - Children: Reduce the dose in the same manner.

Precautions

This drug is a beta-lactam antibiotic and should not be administered to patients allergic to this drug's ingredients or those allergic to penicillin or cephalosporins. In particular, patients with infectious mononucleosis or lymphocytic leukemia are at higher risk of rash when taking this medication and should exercise caution. Patients with a history of liver dysfunction or jaundice caused by this drug or penicillin should avoid use as there is a possibility of recurrence. Caution should be exercised with patients who have poor liver function or moderate to severe kidney impairment as drug concentrations may increase. Patients with allergic predispositions or those who have difficulty swallowing, elderly patients, and those in poor overall condition should be cautious due to the risk of bleeding from vitamin K deficiency. Patients with severe vomiting or diarrhea due to gastrointestinal diseases may have reduced drug absorption. If symptoms like diarrhea, abdominal pain, or bloody stools occur while taking this drug, discontinue immediately and consult a doctor. Symptoms of liver dysfunction may appear during administration or after discontinuation, so liver function tests are necessary with prolonged use. Allergic reactions such as skin rash, itching, and in severe cases Stevens-Johnson syndrome or anaphylactic shock may occur, thus it is essential to inform medical personnel immediately if unusual symptoms appear. Blood abnormalities such as leukopenia and thrombocytopenia may rarely occur, so blood tests are recommended for long-term use. Central nervous system symptoms such as anxiety, confusion, and seizures have been reported rarely, necessitating caution in patients with impaired renal function or those receiving high doses. Avoid use during the first three months of pregnancy, and in cases of pregnancy or breastfeeding, administration should only occur after consulting a doctor. Use is recommended only for children over 12 years of age or those weighing more than 40 kg, and caution should be taken in the elderly due to a higher likelihood of side effects from decreased physical function. This drug has many interactions with other medications and should be used cautiously, especially with anticoagulants, allopurinol, disulfiram, etc., as it may decrease the effectiveness of oral contraceptives. In case of overdose, symptoms such as vomiting, diarrhea, abdominal pain, drowsiness, and seizures may occur, necessitating immediate notification to medical personnel and appropriate treatment. This drug should be stored in a closed container to avoid moisture exposure and kept in a dry location at temperatures below 25 degrees to maintain its effectiveness.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-induced colitis, bloody stool, itching, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, laryngeal edema, anaphylactic shock, leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, convulsions, anti-chorea, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, linear IgA disease, dysgeusia, lethargy, dermatitis, oral edema, gastric pain, electrolyte and fluid imbalance, rash, hyperactivity, drowsiness, renal failure symptoms, interstitial seizures, hypersensitivity shock, skin reactions, bleeding, cytopenia, vomiting, hypotension, neutrophilia, leukocytosis, shock

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to avoid moisture exposure. Additionally, it should be kept in a dry location at temperatures below 25 degrees to maintain its effectiveness.

Appearance and packaging

Appearance

It is an oval film-coated tablet that is white or almost white.

Package unit

100 tablets/box[(10 tablets/PTP*10)], 96 tablets/box[(8 tablets/PTP*12)], 80 tablets/box[(8 tablets/PTP*10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.